1 / 5

Interventional Oncology Market Size, Scope, Growth and Forecast to 2029

The latest report by Precision Business Insights, titled u201cInterventional Oncology Marketu201d covers complete information on market size, share, growth, trends, segment analysis, key players, drivers, and restraints.

shristis030
Download Presentation

Interventional Oncology Market Size, Scope, Growth and Forecast to 2029

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Interventional Oncology Market (2023-29)

  2. Market Overview: The global interventional oncology market size was valued at USD 2.1 billion in 2022, It is expected to reach a value of USD 3.2 billion by 2029, growing at a CAGR of 6.8% from 2023 to 2029. The interventional oncology market research report also provides opportunities for business owners to exploit through the use of relevant approaches. The study’s prospects assist stakeholders and report purchasers in properly planning their investments and augmenting their profits. The report provides a quantitative analysis of the market segments, trends, estimations, and dynamics of theinterventional oncology market analysis from 2023 to 2029 to identify the prevailing market opportunities. In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years. View Detailed Report Description

  3. Market Segments: The interventional oncology market has been fragmented based on: 1. By Product: Embolization Devices (Radioembolic Agents, Non-Radio embolic Agents(Microspheres, Coated Beads, Microparticles)), Ablation Devices (Radiofrequency (RF) Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Other Ablation Devices), Support Devices (Microcatheters, Guidewires) 2. By Procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy, Transcatheter Arterial Embolization/Bland Embolization. 3. By Cancer Type: Liver Cancer, Lung Cancer, Bone Metastasis, Kidney Cancer, Breast Cancer, Prostate Cancer, Other Cancers. 4. By End User: Hospitals, Ambulatory Surgery Centers, Research & Academic Institutes Request Sample Report

  4. Key Players: • Some of the major key players in the interventional oncology market are: • Boston Scientific Corporation • Medtronic PLC • Terumo Corporation • Merit Medical Systems Inc. • CR Bard Inc. • Profound Medical Corp. • AngioDynamics Inc. • Cook Medical LLC • HealthTronics Inc. • Request Sample Report

  5. Europe Office: Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Asia-Pacific Office: Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad – 500072 Email: sales@precisionbusinessinsights.com Toll-Free: +1-866-598-1553

More Related